AOP Health
Mag. Dagmar Schiefer currently serves as Key-Account-Manager for Hematology & Oncology at AOP Health since November 2022. Prior experience includes significant roles at Eli Lilly from July 2009 to November 2022, focusing on oncology as a scientific sales representative and previously as a product specialist in diabetology. Other key positions have included oncology clinical representative roles at Merck Darmstadt and Bristol Meyers Squibb Medical, and a medical liaison position at Eli Lilly. Early career experience also includes roles in pharmaceutical sales at GSK, F. Hoffmann-La Roche, and Wyeth-Lederle Pharma. Dagmar Schiefer holds a Mag.phil. degree in Pedagogy and Psychology from Universität Klagenfurt, obtained between 1984 and 1988.
AOP Health
1 followers
Previously known as AOP Orphan, AOP Health is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the company has become an established provider of integrated therapy solutions from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. This development has been made possible by a continually high level of investment in research and development on the one hand and a highly consistent and pragmatic orientation towards the needs of all our stakeholders on the other - especially the patients and their families as well as also the doctors and care professionals treating them. Needs. Science. Trust. The international healthcare group focuses on research, development and global sales of innovative treatment solutions. AOP Health believes it has a responsibility to make innovative integrated therapies and disease-management solutions available long term to as many patients as possible who suffer from rare diseases or require critical care. Data protection information: https://www.aop-health.com/global_en/footer/privacy-policy